LGM
IMUX icon

Logos Global Management’s Immunic IMUX Stock Holding History

Logos Global Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,118
Closed -$556K – 67
2024
Q1 		$556K Hold
42,118
– – 0.05% 55
2023
Q4 		$632K Hold
42,118
– – 0.06% 52
2023
Q3 		$619K Hold
42,118
– – 0.08% 52
2023
Q2 		$1.06M Hold
42,118
– – 0.14% 48
2023
Q1 		$628K Buy
+42,118
New +$782K 0.09% 41

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Logos Global Management's IMUX Position: Q2 2024 in Review

Logos Global Management sold out of Immunic (IMUX) in Q2 2024, closing a stake of 42,118 shares — an estimated $556K sold.

Logos Global Management first reported a position in IMUX in Q1 2023 and held it in 5 quarters. The position peaked at $1.06M in Q2 2023. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2024.

  • Logos Global Management reported no remaining Immunic position as of Q2 2024 after selling out during the quarter.
  • Logos Global Management sold 42,118 Immunic shares in Q2 2024, an estimated $556K.
  • Logos Global Management first reported a position in Immunic in Q1 2023 and held it in 5 quarters.
  • Logos Global Management's Immunic position peaked at $1.06M in Q2 2023.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2024.

Based on Logos Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.